Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia

Venetoclax creates ongoing challenges when combined with posaconazole due to a known drug-drug interaction. Herein, we investigated the safety between venetoclax 100mg and 70mg when administered with posaconazole in acute myeloid leukemia in this single-center, retrospective comparative analysis. Pr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tracelyn Freeman, Alma Habib, Ying Huang, Pooja S. Kumar, Allyson Waller, Megan Fleming, Kelsey McMillan, Natalia Hartzler, Gregory Behbehani, James S. Blachly, Bradley W. Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole R. Grieselhuber, Shivani Handa, Karilyn Larkin, Shinae Lee, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Jayanshu Jain, Kieran Sahasrabudhe, Kristin Koenig
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-09-01
Saila:	Frontiers in Hematology
Gaiak:	venetoclax posaconazole leukemia dosing interaction myeloid
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/frhem.2025.1664425/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!